These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 1728401

  • 1. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M, Bicknell R, Harris AL.
    Cancer Res; 1992 Jan 15; 52(2):275-9. PubMed ID: 1728401
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
    Zugmaier G, Ennis BW, Deschauer B, Katz D, Knabbe C, Wilding G, Daly P, Lippman ME, Dickson RB.
    J Cell Physiol; 1989 Nov 15; 141(2):353-61. PubMed ID: 2808542
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL, Lee AV, Yee D.
    Cancer Res; 1998 Sep 15; 58(18):4199-205. PubMed ID: 9751635
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.
    Danforth DN, Sgagias MK.
    Cancer Res; 1993 Apr 01; 53(7):1538-45. PubMed ID: 8453620
    [Abstract] [Full Text] [Related]

  • 5. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 01; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK.
    Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.
    Arrick BA, Korc M, Derynck R.
    Cancer Res; 1990 Jan 15; 50(2):299-303. PubMed ID: 2295070
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 9. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP, Jordan VC.
    Cancer Res; 1989 Apr 01; 49(7):1758-62. PubMed ID: 2522347
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 01; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 12. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A, Price JE, García-Ramirez M, Méndez O, López L, Fabra A.
    Lab Invest; 1997 Oct 01; 77(4):357-68. PubMed ID: 9354770
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
    Mohamood AS, Gyles P, Balan KV, Hollis VW, Eckberg WR, Asseffa A, Han Z, Wyche JH, Anderson WA.
    J Submicrosc Cytol Pathol; 1997 Jan 01; 29(1):1-17. PubMed ID: 9066137
    [Abstract] [Full Text] [Related]

  • 14. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR, Sutherland RL.
    Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C, Hollander C, Miller B.
    Cancer Res; 1986 May 15; 46(5):2276-81. PubMed ID: 3697973
    [Abstract] [Full Text] [Related]

  • 17. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
    Danforth DN, Sgagias MK.
    Cancer Res; 1991 Mar 01; 51(5):1488-93. PubMed ID: 1997187
    [Abstract] [Full Text] [Related]

  • 18. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr 01; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 20. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ, Zhu BT.
    J Steroid Biochem Mol Biol; 2004 Mar 01; 88(3):265-75. PubMed ID: 15120420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.